We previously dissected the intra-tumoral changes in ICC following ICB therapy via single-cell analyses, highlighting the strategy of targeting SPP1+ macrophages and VEGF signaling (17). This evidence concerns the gene VEGFA and intrahepatic cholangiocarcinoma.